Skip to content
10-Q

Quarterly Report

ELECTROMEDICAL TECHNOLOGIES, INC. EMED

0001410578-23-001112

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 12, 2023 309.68M sh
Cash And Equivalents Q1 2023 · Mar 31, 2023 $1.24M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $368.43K
Current Liabilities Q1 2023 · Mar 31, 2023 $2.44M
Current Liabilities Q1 2023 · Dec 31, 2022 $2.92M
Total Liabilities Q1 2023 · Mar 31, 2023 $2.6M
Total Liabilities Q1 2023 · Dec 31, 2022 $3.57M
Current Assets Q1 2023 · Mar 31, 2023 $1.57M
Current Assets Q1 2023 · Dec 31, 2022 $647.8K
Total Assets Q1 2023 · Mar 31, 2023 $1.57M
Total Assets Q1 2023 · Dec 31, 2022 $1.35M
Shares Diluted Q1 2023 · Mar 31, 2022 97.26M sh
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$317.85K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$1.7M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$722.5K
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.01
Eps Basic Q1 2023 · Mar 31, 2022 −$0.01
Sga Expense Q1 2023 · Mar 31, 2022 $879.81K
Net Income Q1 2023 · Mar 31, 2022 −$1.14M
Operating Income Q1 2023 · Mar 31, 2022 −$725.56K
Gross Profit Q1 2023 · Mar 31, 2022 $154.25K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $67.64K
Revenue Q1 2023 · Mar 31, 2022 $221.89K